ImmuCell Corporation (ICCC) Operating margin 2017–2025
ImmuCell Corporation (ICCC) operating margin by fiscal year — reported operating income divided by reported revenue.
6.0%FY2025 · since FY2017: -2.3% → 6.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 6.0% | +12.2 pp |
| FY2024 | -6.2% | +26.7 pp |
| FY2023 | -32.9% | -20.5 pp |
| FY2022 | -12.4% | -13.7 pp |
| FY2021 | 1.3% | +10.3 pp |
| FY2020 | -9.0% | -2.0 pp |
| FY2019 | -7.0% | +6.2 pp |
| FY2018 | -13.2% | -10.8 pp |
| FY2017 | -2.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice